219762-28-4

Basic information

• Product Name: 5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine
• Synonyms: 5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine;5-broMo-2-Methyl-3H-iMidazo[4;5-Bromo-2-methyl-1H-imidazo[4,5-b]pyridine, 6-Bromo-2-methyl-7-azabenzimidazole;5-Bromo-2-methyl-1H-imidazo[4,5-b]pyridine
• CAS NO: 219762-28-4
• Molecular Formula: C₇H₆BrN₃
• Molecular Weight: 212.04664
• Mol File: 219762-28-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 415.918°C at 760 mmHg
• Flash Point: 205.34°C
• Appearance: /
• Density: 1.756g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.711
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 7.69±0.40(Predicted)
• CAS DataBase Reference: 5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine(219762-28-4)
• EPA Substance Registry System: 5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine(219762-28-4)

Safety Data

• Hazardous Substances Data: 219762-28-4(Hazardous Substances Data)

Usage

General Description

5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine is a chemical compound with the molecular formula C8H6BrN3. It is a heterocyclic compound with a fused imidazole and pyridine ring structure. 5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine is used in medicinal chemistry as a building block for the synthesis of various pharmaceuticals and agrochemicals. It has shown potential as an antitumor agent and has also been studied for its potential use in the treatment of neurological disorders. Additionally, it has been investigated for its antimicrobial and antiviral properties. While further research is needed to fully understand its potential applications, 5-bromo-2-methyl-3H-imidazo[4,5-b]pyridine shows promise as a versatile and valuable chemical compound in various fields of research.

InChI:InChI=1/C7H6BrN3/c1-4-9-5-2-3-6(8)11-7(5)10-4/h2-3H,1H3,(H,9,10,11)

Upstream product

• 129012-04-0 2,3-Diamino-6-bromopyridine 
• 78-39-7 Triethyl orthoacetate 
• 40851-92-1 5-chloro-2-methyl-1⁽³⁾H-imidazo[4,5-b]pyridine 
• 219766-89-9 2-(acetamido)-6-bromo-3-nitropyridine 
• 55304-80-8 2,6-dibromo-3-nitropyridine 
• 84487-04-7 6-bromo-3-nitro-pyridin-2-ylamine 
• 40851-95-4 6-chloropyridine-2,3-diamine 
• 219767-18-7 2-amino-6-bromo-3-nitropyridine hydrobromide 
• 27048-04-0 2-amino-6-chloro-3-nitropyridine 
• 1445-45-0 Trimethyl orthoacetate 

Downstream Products

• 219762-30-8 2-methyl-1H-imidazo[4,5-b]pyridine-5-carbonitrile 
• 219763-03-8 5-bromo-3-(2-chloro-4-phenylbenzyl)-2-methyl-3H-imidazo[4,5-b]pyridine 
• 219763-04-9 5-bromo-1-(2-chloro-4-phenylbenzyl)-2-methyl-1H-imidazo[4,5-b]pyridine 
• 219762-51-3 5-bromo-1-(2-bromo-4-chlorobenzyl)-2-methyl-1H-imidazo[4,5-b]pyridine 
• 219762-50-2 5-bromo-3-(2-bromo-4-chlorobenzyl)-2-methyl-3H-[4,5-b]pyridine 

Relevant articles and documents

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES

Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Sulfonamide compounds and medicinal use thereof

A sulfonamide compound of the formula (I):R 1 --SO 2 NHCO--A--R 2 (I)wherein R 1 is alkyl, alkenyl, alkynyl and the like; A is an optionally substituted heteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R 2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.